ACUMEN BIOMEDICAL LIMITED
Opportunity 76/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: share sale to pe / searcher (73/100).
Data confidence
Overall: high (80/100)Strong data coverage across all sections. AI outputs should be trusted with minimal caveats.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Signals from accounts
Derived from iXBRL accounts · FRS 102Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 102| Metric | 2025-05-31 | 2024-05-31 |
|---|---|---|
| Total assets | £75.5k | £63.1k |
| Current assets | £79.1k | £65.2k |
| Cash | £79.1k | £65.1k |
| Debtors | £73 | £125 |
| Net assets | £75.5k | £63.1k |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 confirmation-statement
- • 1 confirmation-statement
- • 1 address
- • 1 accounts
Corporate timeline (12 events)Click to expand
- 2026-04-21📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2026-02-26📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2025-02-20📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-12-20📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-08-08📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2023-02-28📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2022-02-25📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2021-02-17📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2020-01-10📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2018-05-09🏢Company incorporatedAs ACUMEN BIOMEDICAL LIMITED
- 2018-05-09➕PERCIVAL, Steven Lane, Dr appointeddirector
- 2018-05-09📄incorporation-companyincorporation · NEWINC
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Senior director age: Director aged approximately 60 — approaching natural succession window.
- +No director turnover: Company is 8 years old with no director changes — suggests a very tight-knit founder team never broadened.
Succession & seller-readiness
Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.
- secondaryFounder aged 58+: Senior director is approximately 60. Early succession window.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Dr Steven Lane Percival Individual · British · DOB 11/1966 · age 60 | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 09/05/2018 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Professional services · CH postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| A STAR SUPPORT GROUP LTD→ 11589504 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| APEX LEADERSHIP LTD→ 07094271 · est 2009 · no financials extracted | — | — | — | — | 16y | — | — |
| ARCC HR LTD→ 09859800 · est 2015 · no financials extracted | — | — | — | — | 10y | — | — |
| ARENAL LIMITED→ 08488655 · est 2013 · no financials extracted | — | — | — | — | 13y | — | — |
| ARION PROJECT MANAGEMENT LIMITED→ 08457658 · est 2013 · no financials extracted | — | — | — | — | 13y | — | — |
| ARISAM CAPITAL LTD→ 17102527 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| ARK COMMERCIAL TRANSPORT LIMITED→ 08204226 · est 2012 · no financials extracted | — | — | — | — | 13y | — | — |
| ARK SEARCH LIMITED→ 13138326 · est 2021 · no financials extracted | — | — | — | — | 5y | — | — |
| ARMOUR WILLS & ESTATE PLANNING LTD→ 14009794 · est 2022 · no financials extracted | — | — | — | — | 4y | — | — |
| ARMSTRONG TOMKINS & CO LTD→ 03433134 · est 1997 · no financials extracted | — | — | — | — | 28y | — | — |
| ARONNAX ULTRASOUND LIMITED→ 14255438 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| ARROW ASSET MANAGEMENT LTD→ 09546117 · est 2015 · no financials extracted | — | — | — | — | 11y | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.